Company | Timeline | Status | |
Glaxosmithkline Intellectual Property (No.5) Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←11 Months→Current | Liquidation | |
Glaxosmithkline Intellectual Property (No.4) Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←11 Months→Current | Active | |
Glaxosmithkline Intellectual Property (No.3) Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←11 Months→Current | Active | |
Glaxosmithkline Intellectual Property Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←11 Months→Current | Active | |
Glaxosmithkline Intellectual Property Holdings Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←11 Months→Current | Active | |
Glaxosmithkline Intellectual Property Development Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←11 Months→Current | Active | |
Glaxosmithkline Intellectual Property (No.2) Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←11 Months→Current | Active | |
Glaxosmithkline Intellectual Property Management Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←11 Months→Current | Active | |
Glaxo Wellcome UK Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←11 Months→Current | Active | |
Glaxosmithkline Intellectual Property (No.5) Limited Director • Vp Oncology, R&d Finance | 23 Sep 2024←6 Months→31 Mar 2025 | Liquidation |